Cargando…
Genotyping performance evaluation of commercially available HIV-1 drug resistance test
BACKGROUND: ATCC HIV-1 drug resistance test kit was designed to detect HIV-1 drug resistance (HIVDR) mutations in the protease and reverse transcriptase genes for all HIV-1 group M subtypes and circulating recombinant forms. The test has been validated for both plasma and dried blood spot specimen t...
Autores principales: | Rosemary, Audu, Chika, Onwuamah, Jonathan, Okpokwu, Godwin, Imade, Georgina, Odaibo, Azuka, Okwuraiwe, Zaidat, Musa, Philippe, Chebu, Oliver, Ezechi, Oche, Agbaji, David, Olaleye, Jay, Samuel, Ibrahim, Dalhatu, Mukhtar, Ahmed, Joshua, DeVos, Chunfu, Yang, Elliot, Raizes, Beth, Chaplin, Phyllis, Kanki, Emmanuel, Idigbe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023177/ https://www.ncbi.nlm.nih.gov/pubmed/29953436 http://dx.doi.org/10.1371/journal.pone.0198246 |
Ejemplares similares
-
Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study
por: Onwuamah, Chika K., et al.
Publicado: (2020) -
Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
por: Meloni, Seema T, et al.
Publicado: (2017) -
Accumulation of Protease Mutations among Patients Failing Second-Line Antiretroviral Therapy and Response to Salvage Therapy in Nigeria
por: Rawizza, Holly E., et al.
Publicado: (2013) -
Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment Program
por: Meloni, Seema T., et al.
Publicado: (2017) -
Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART
por: Rawizza, Holly E, et al.
Publicado: (2020)